Pro Medicus Ltd
ASX:PME
Operating Margin
Pro Medicus Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
23.5B AUD |
73%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
36.7B USD |
25%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
13%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
10.6B USD |
41%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.2T JPY |
21%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.3B USD |
13%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
54.8B SEK |
-28%
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD |
4%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
244.2B INR | N/A | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
20.4B CNY |
16%
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
0%
|
Pro Medicus Ltd
Glance View
Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments. The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Pro Medicus Ltd's most recent financial statements, the company has Operating Margin of 73.2%.
You don't have any saved screeners yet